Comprehensive Front-Line Screening: Tear Film, Eyelids, and Meibomian Glands

Most dry eye cases involve either tear film instability or meibomian gland dysfunction (MGD)—often both.

Together, they allow the practice to:

This eliminates reliance on subjective symptom questionnaires alone and enables clinically defensible screening within minutes.

Minimal Learning Curve, Immediate Clinical Deployment

For startup practices, time to adoption matters more than feature depth.

• No complex calibration or interpretation required

• Imaging and results are intuitive for both staff and patients

• Can be delegated to technicians after minimal training

This means:

• Dry eye screening can be added immediately without disrupting existing workflows

• No dependency on a dry eye "specialist"  to start generating value

Strong Patient Education and Conversion Capability

Dry eye treatment acceptance depends on whether patients understand their condition.

For practices planning to introduce:

The screening pack becomes the conversion engine, not just a diagnostic tool.

Low Capital Investment, Fast ROI

Compared to advanced diagnostic platforms, the screening pack:

• Requires significantly lower upfront investment

• Has minimal consumable or maintenance burden

• Can be monetized as:

• A paid screening service, or

• A bundled pre-treatment evaluation

This allows practices to:

• Validate local demand for dry eye services

• Generate revenue before committing to higher-cost therapeutic equipment

• Scale progressively, not speculatively

Future-Proof and Upgrade-Friendly

The screening pack does not lock the practice into a dead-end system.

• MeiboVue integrates well with future treatment workflows

• Screening data remains clinically relevant when IPL or expression devices are added

• Acts as the foundation layer of a modular dry eye service model

Practices can start small, then expand with confidence.

Summary: Designed for Speed, Clarity, and Growth

The QuikVue + MeiboVue Dry Eye Screening Pack enables practices to:

• Launch dry eye services quickly

• Screen efficiently and objectively

• Educate patients visually

• Convert consultations into treatments

• Achieve early ROI with low operational risk

For startup or early-stage practices, it is not a compromise solution—it is a strategic starting point.

View Pack Details